BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 24583412)

  • 1. Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.
    Mariotti J; Maura F; Spina F; Roncari L; Dodero A; Farina L; Montefusco V; Carniti C; Sarina B; Patriarca F; Rambaldi A; Onida F; Olivieri A; Zallio F; Corradini P
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):885-90. PubMed ID: 24583412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical outcomes of cytomegalovirus diseases in hematologic malignancy patients without hematopoietic stem-cell transplantation.
    Yang J; Kang CI; Lee YH; Ko JH; Huh K; Cho SY; Chung DR; Peck KR; Jung CW
    Support Care Cancer; 2023 Dec; 32(1):56. PubMed ID: 38133709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping.
    Wu X; Ma X; Song T; Liu J; Sun Y; Wu D
    Ann Hematol; 2024 Mar; 103(3):917-933. PubMed ID: 38227006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation.
    Wen Q; Guo Z; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Sun YQ; Huang XJ; Mo XD
    Sci Rep; 2024 May; 14(1):11778. PubMed ID: 38782966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation.
    Ljungman P
    Curr Opin Hematol; 2014 Nov; 21(6):466-9. PubMed ID: 25159712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection is associated with rapid NK differentiation and reduced incidence of relapse in HLA matched sibling donor transplant patients.
    Han T; Xie J; Zhao X; Lv M; Chang Y; Xu L; Wang Y; Zhang X; Liu K; Huang XJ; Zhao XY
    Clin Exp Immunol; 2022 Dec; 210(3):283-294. PubMed ID: 36383237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence.
    Janković M; Knežević A; Todorović M; Đunić I; Mihaljević B; Soldatović I; Protić J; Miković N; Stoiljković V; Jovanović T
    Virol J; 2022 Sep; 19(1):155. PubMed ID: 36171605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus in Haematological Tumours.
    Alonso-Álvarez S; Colado E; Moro-García MA; Alonso-Arias R
    Front Immunol; 2021; 12():703256. PubMed ID: 34733270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of HCMV in allogenic and autologous stem cell transplantation by real-time PCR in Kermanshah, west of Iran.
    Payandeh M; Zamanian MH; Nomanpour B; Farhadi MS; Janbakhsh A; Rostamian M; Elahi A; Jafari S; Dehghannejad M
    Infect Agent Cancer; 2021 Feb; 16(1):8. PubMed ID: 33531035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV).
    Barnes S; Schilizzi O; Audsley KM; Newnes HV; Foley B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where do we Stand after Decades of Studying Human Cytomegalovirus?
    Gugliesi F; Coscia A; Griffante G; Galitska G; Pasquero S; Albano C; Biolatti M
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32397070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Stern L; Withers B; Avdic S; Gottlieb D; Abendroth A; Blyth E; Slobedman B
    Front Microbiol; 2019; 10():1186. PubMed ID: 31191499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
    Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J
    Front Immunol; 2018; 9():389. PubMed ID: 29545802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas.
    Mehravaran H; Makvandi M; Samarbaf Zade A; Neisi N; Kiani H; Radmehr H; Shahani T; Hoseini SZ; Ranjbari N; Nahid Samiei R
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):593-597. PubMed ID: 28440608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant.
    Peled JU; Jenq RR
    Leuk Lymphoma; 2017 Apr; 58(4):759-761. PubMed ID: 27733072
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).
    Pohlen M; Groth C; Sauer T; Görlich D; Mesters R; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Berdel WE; Stelljes M
    Bone Marrow Transplant; 2016 Nov; 51(11):1441-1448. PubMed ID: 27295269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
    Teira P; Battiwalla M; Ramanathan M; Barrett AJ; Ahn KW; Chen M; Green JS; Saad A; Antin JH; Savani BN; Lazarus HM; Seftel M; Saber W; Marks D; Aljurf M; Norkin M; Wingard JR; Lindemans CA; Boeckh M; Riches ML; Auletta JJ
    Blood; 2016 May; 127(20):2427-38. PubMed ID: 26884374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.